Diagnostic and therapeutic value of apomorphine in Parkinsonian patients

International Journal of Clinical Practice

Volumn 58, Issue 11, 2004, Pages 1028-1032

  Sharma, Jagdish C ^a   Macnamara, L ^a   Hasoon, M ^a   Vassallo, M ^b  

^a Mansfield Community Hospital   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APOMORPHINE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HALLUCINATION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; MALE; MOTOR DYSFUNCTION; NAUSEA AND VOMITING; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME; TREMOR;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 10444222575     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00357.x     Document Type: Article

References (11)

1. Kempster PA, Frankel JP, Stern GM, Lees AJ. Comparison of motor response to apomorphine and levodopa in Parkinson's disease. J Neurol Neurosurg Psychiatry 1990; 53: 1004-7.
2. Lees AJ. Dopamine agonists in Parkinson's disease: a look at apomorphine. Fundam Clin Pharmacol 1993; 7: 121-8.
3. Cotzias GC, Papavasiliou PS, Tolosa EA, Mendez JS, Bell-Midura M. Treatment of Parkinson's disease with apomorphine. N Engl J Med 1976; 294: 567-72.
4. Colzi A, Turner K, Lees AJ. Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 64: 573-6.
5. Hughes AJ. Apomorphine test in the assessment of parkinsonian patients: a meta-analysis. Adv Neurol 1999; 80: 363-8.
6. Dewey RB Jr. Management of motor complications in Parkinson's disease. Neurology 2004; 62 (Suppl. 4): S3-7.
7. Factor SA. Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease. Neurology 2004; 62 (Suppl. 4): S12-17.
8. LeWitt PA. Subcutaneously administered apomorphine: pharmacokinetics and metabolism. Neurology 2004; 62 (Suppl. 4): S8-11.
9. Swope DM. Rapid treatment of "wearing off" in Parkinson's disease. Neurology 2004; 62 (Suppl. 4): S27-31.
10. MacMahon D. The use of apomorphine in older patient. ACNR 2003; 3: 30-1.
11. Poewe W, Wenning GK. Apomorphine: an underutilized therapy for Parkinson's disease. Mov Disord 2000; 15: 789-94.